Omalizumab
Links shared publicly online about this topic
Omalizumab beyond asthma
elsevier.es — “Omalizumab beyond asthma” View full resource at elsevier.es
Most Recently Shared on March 14, 2012 at 1:06 pm By:
Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician
Omalizumab beyond asthma. (full text, pdf) http://t.co/JQufcLyA
Gastroenterology Article | Omalizumab
mdlinx.com — “Omalizumab in the treatment of eosinophilic esophagitis and food allergy” View full resource at mdlinx.com
Most Recently Shared on August 29, 2011 at 11:42 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Omalizumab in the treatment of eosinophilic esophagitis and food allergy: European Journal of Pediatrics http://t.co/jjWE4jU #GI
Pediatrics Article | Omalizumab
mdlinx.com — “Omalizumab in the treatment of eosinophilic esophagitis and food allergy” View full resource at mdlinx.com
Most Recently Shared on August 29, 2011 at 1:19 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Omalizumab in the treatment of eosinophilic esophagitis and food allergy: European Journal of Pediatrics http://t.co/7oW3O4G #peds
Allergy/Immunology Article | Omalizumab
mdlinx.com — “Omalizumab in the treatment of eosinophilic esophagitis and food allergy” View full resource at mdlinx.com
Most Recently Shared on August 29, 2011 at 3:06 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Omalizumab in the treatment of eosinophilic esophagitis and food allergy: European Journal of Pediatrics http://t.co/slrYlGu #Allergy
Xolair- All About Xolair (Omalizumab)
asthma.about.com — “Xolair (omalizumab) is a medication used to treat allergic asthma when your doctor is having problems controlling your symptoms with other medication. Learn what you need to know about Xolair (omalizumab) including indications, how it works and important side effects.” View full resource at asthma.about.com
Most Recently Shared on September 17, 2010 at 10:16 pm By:
Pat Physician, Doctor, Pediatrician, and Internist
Xolair- All About Xolair (Omalizumab) - http://bit.ly/dvGJOO
Omalizumab for Asthma | Now@NEJM
blogs.nejm.org — “In the Original Article, Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children, Busse et al. found the introduction of guidelines-based” View full resource at blogs.nejm.org
Most Recently Shared on March 18, 2011 at 5:03 pm By:
NEJM: Omalizumab for Asthma http://bit.ly/gaKbpj
Omalizumab for Asthma | Now@NEJM
blogs.nejm.org — “In the Original Article, Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children, Busse et al. found the introduction of guidelines-based” View full resource at blogs.nejm.org
Most Recently Shared on March 18, 2011 at 5:53 pm By:
Thomas Loarie, Jr Health Advocate
@NEJM Omalizumab for Asthma http://bit.ly/gOpbOb #medical #journal
Asthma Symptoms, Future Attacks Reduced By Omalizumab
medicalnewstoday.com — “Researchers from Boston University School of Medicine (BUSM), in collaboration with researchers from the Inner City Asthma Consortium, have found that among inner-city children, the drug omalizuma” View full resource at medicalnewstoday.com
Most Recently Shared on March 17, 2011 at 11:05 am By:
Asthma Symptoms, Future Attacks Reduced By Omalizumab http://mnt.to/3Spy #asthma
YouTube - Omalizumab for Milk Allergy
youtube.com — “Off-label pretreatment with the biologic drug omalizumab (Xolair) enabled relatively rapid oral desensitization to milk allergy in a small, pilot study of 11...” View full resource at youtube.com
Most Recently Shared on April 29, 2011 at 3:51 pm By:
Omalizumab for Milk Allergy http://bit.ly/jxM6yJ
ingentaconnect Omalizumab: Various toxicities: case report
ingentaconnect.com — “ingentaconnect Omalizumab: Various toxicities: case report” View full resource at ingentaconnect.com
Most Recently Shared on February 21, 2011 at 4:50 pm By:
Omalizumab: Various toxicities: case report: (Source: Reactions) http://bit.ly/geNzjT
ingentaconnect Clinical efficacy of omalizumab in an elderly veteran population ...
ingentaconnect.com — “ingentaconnect Clinical efficacy of omalizumab in an elderly veteran population ...” View full resource at ingentaconnect.com
Most Recently Shared on September 26, 2011 at 5:10 am By:
Clinical efficacy of omalizumab in an elderly veteran population with severe asthma: (Source: Allergy and Asthma... http://t.co/HJXLH8Hu
NICE rejects omalizumab for asthma in children | GP online
gponline.com — “Using omalizumab (Xolair) to treat children with persistent allergic asthma does not represent good value for NHS money, NICE has said.” View full resource at gponline.com
Most Recently Shared on August 12, 2010 at 9:26 am By:
GPonline.com Medical Education and Medical Publisher
NICE rejects omalizumab for asthma in children http://bit.ly/9EiIVy
NICE rejects omalizumab for asthma in children | Healthcare Republic
healthcare.tweetmeme.com — “All the news on healthcare” View full resource at healthcare.tweetmeme.com
Most Recently Shared on August 12, 2010 at 9:36 am By:
Healthcare TweetMeme Health Social Media
NICE rejects omalizumab for asthma in children | Healthcare Republic http://retwt.me/1OgPc (via @HealthcareRep)
News - FDA: Ongoing Omalizumab Study Shows Increased Number of Cardiovascular Events
docguide.com — “FDA: Ongoing Omalizumab Study Shows Increased Number of Cardiovascular Events” View full resource at docguide.com
Most Recently Shared on July 16, 2009 at 10:08 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
Xolair (omalizumab) possible new side effects reported: http://bit.ly/ZIuy9
Good Response to Omalizumab at 16 Weeks Is Predictive --Doctors Lounge
doctorslounge.com — “Good Response to Omalizumab at 16 Weeks Is Predictive --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on February 4, 2011 at 1:12 am By:
Michael Blaiss, MD Doctor, Allergist, and Physician
Good Response to Omalizumab at 16 Weeks Is Predictive --Doctors Lounge http://t.co/pErzGvv
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Juan C. Ivancevich, MD
Allergist - Head Allergy & Immunology, Santa Isabel Clinic, Buenos Aires. Assistant Professor of Immunology, Medicine School, Universidad del Salvador, Buenos Aires. Member of the Board of Directors, World Allergy Organization. President of the South Cone Chapter on the Latin American Society of Allergy, Asthma & Immunology.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
